Standard BioTools Statistics
Total Valuation
LAB has a market cap or net worth of $599.34 million. The enterprise value is $322.48 million.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LAB has 372.26 million shares outstanding. The number of shares has increased by 253.41% in one year.
Current Share Class | 372.26M |
Shares Outstanding | 372.26M |
Shares Change (YoY) | +253.41% |
Shares Change (QoQ) | -0.21% |
Owned by Insiders (%) | 1.38% |
Owned by Institutions (%) | 51.46% |
Float | 237.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.89 |
Forward PS | 2.81 |
PB Ratio | 1.22 |
P/TBV Ratio | 1.67 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.07 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.18.
Current Ratio | 3.76 |
Quick Ratio | 3.33 |
Debt / Equity | 0.18 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -26.26 |
Financial Efficiency
Return on equity (ROE) is -37.25% and return on invested capital (ROIC) is -17.47%.
Return on Equity (ROE) | -37.25% |
Return on Assets (ROA) | -14.69% |
Return on Capital (ROIC) | -17.47% |
Revenue Per Employee | $289,243 |
Profits Per Employee | -$316,518 |
Employee Count | 539 |
Asset Turnover | 0.31 |
Inventory Turnover | 2.48 |
Taxes
In the past 12 months, LAB has paid $139,000 in taxes.
Income Tax | 139,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.13% in the last 52 weeks. The beta is 1.57, so LAB's price volatility has been higher than the market average.
Beta (5Y) | 1.57 |
52-Week Price Change | -28.13% |
50-Day Moving Average | 1.89 |
200-Day Moving Average | 2.20 |
Relative Strength Index (RSI) | 38.92 |
Average Volume (20 Days) | 2,754,154 |
Short Selling Information
The latest short interest is 19.54 million, so 5.25% of the outstanding shares have been sold short.
Short Interest | 19.54M |
Short Previous Month | 21.33M |
Short % of Shares Out | 5.25% |
Short % of Float | 8.24% |
Short Ratio (days to cover) | 12.07 |
Income Statement
In the last 12 months, LAB had revenue of $155.90 million and -$170.60 million in losses. Loss per share was -$0.62.
Revenue | 155.90M |
Gross Profit | 75.71M |
Operating Income | -119.93M |
Pretax Income | -118.58M |
Net Income | -170.60M |
EBITDA | -114.31M |
EBIT | -119.93M |
Loss Per Share | -$0.62 |
Full Income Statement Balance Sheet
The company has $366.33 million in cash and $89.47 million in debt, giving a net cash position of $276.86 million or $0.74 per share.
Cash & Cash Equivalents | 366.33M |
Total Debt | 89.47M |
Net Cash | 276.86M |
Net Cash Per Share | $0.74 |
Equity (Book Value) | 489.33M |
Book Value Per Share | 1.31 |
Working Capital | 332.99M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$143.46 million and capital expenditures -$5.05 million, giving a free cash flow of -$148.51 million.
Operating Cash Flow | -143.46M |
Capital Expenditures | -5.05M |
Free Cash Flow | -148.51M |
FCF Per Share | -$0.40 |
Full Cash Flow Statement Margins
Gross margin is 48.57%, with operating and profit margins of -76.92% and -79.91%.
Gross Margin | 48.57% |
Operating Margin | -76.92% |
Pretax Margin | -79.83% |
Profit Margin | -79.91% |
EBITDA Margin | -73.32% |
EBIT Margin | -76.92% |
FCF Margin | -95.89% |
Dividends & Yields
LAB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -253.41% |
Shareholder Yield | -253.41% |
Earnings Yield | -28.47% |
FCF Yield | -24.78% |
Analyst Forecast
The average price target for LAB is $2.88, which is 78.88% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $2.88 |
Price Target Difference | 78.88% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 31.13% |
EPS Growth Forecast (5Y) | -61.74% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LAB has an Altman Z-Score of -0.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.21 |
Piotroski F-Score | 4 |